[Tridazol efficacy and tolerance in the treatment of lambliasis].
The data on the clinical trials of the antiprotozoan agent tridazole-500 are presented. Drug parasitocidal activity and tolerance have been determined. The treatment was performed in 31 patients with lambliasis. A satisfactory drug tolerance and a 77.4% efficacy have been established.